Exposure to Noise or Music in Clinical Trials: A Scoping Review on Ethical and Methodological Considerations

被引:0
|
作者
Iliadou, Eleftheria [1 ,2 ]
Bitzios, Vasileios [1 ]
Pastiadis, Konstantinos [3 ]
Plack, Christopher J. [4 ,5 ]
Bibas, Athanasios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Otorhinolaryngol Head & Neck Surg 1, Athens, Greece
[2] Royal Natl ENT & Dent Eastman Hosp UCLH, London, England
[3] Aristotle Univ Thessaloniki, Thessaloniki, Greece
[4] Univ Manchester, Manchester Ctr Audiol & Deafness, Manchester, England
[5] Univ Lancaster, Dept Psychol, Lancaster, England
来源
NOISE & HEALTH | 2024年 / 26卷 / 122期
关键词
Music; Temporary threshold shift; Hearing loss; Noise; Review; TEMPORARY THRESHOLD SHIFT; INDUCED HEARING-LOSS; OTOACOUSTIC EMISSIONS; SALIVARY CORTISOL; SUBJECTIVE STRESS; EARLY PROGNOSIS; BAND NOISE; HUMANS; PREVENTION; PRESSURE;
D O I
10.4103/nah.nah_41_23
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Background: Use of noise or music in experimental human studies requires balancing the need to avoid subjecting participants to potentially harmful noise levels while still reaching levels that will produce a measurable change in the primary outcome. Several methodological and ethical aspects must be considered. This study aims to summarize ethical and methodological aspects, and reported outcomes, of previously published experimental paradigms using loud noise/music. Methods and materials: Four databases (Medline, Central, Web of Science, and Scopus) and two trials registries (Clinicaltrials.gov and EU Clinical Trials) were searched. Extracted items had the details of author and year of publication, study design and purpose, population, setting timeline and material, selected battery test, and effect of noise/music on participants' hearing. Results: Thirty-four studies were included. Exposure safety considerations were reported in five studies. Eleven studies assessing hearing loss used white or narrow-band noise [(NBN (0.5-4 kHz), up to 115 dBA, duration range: 3 '-24 hours)], and 10 used pop music (up to 106 dBA, duration range: 10 '-4 hours). Experimental setting varied significantly. Temporary thresholds shift (TTS) and reduction in distortion product otoacoustic emissions were found at 1-8 kHz, with maximum average TTS similar to 21.5 dB at 4 kHz after NBN and similar to 11.5 dB at 6 kHz after music exposure. All participants recovered their hearing, except for one participant in one study. In the 13 non-hearing loss studies, no hearing testing was performed after exposure, but loud noise was associated with temporary stress, bradygastria, and cardiovascular changes. Noise-induced subjective stress may be higher for participants with tinnitus. Loud noise (100 dBA, 10 ') increased diastolic and mean blood pressure only in participants with hypertension. Conclusion: Experimental exposure paradigms can produce temporary changes to hearing without measurable long-term health consequences. Methodological and ethical aspects identified in this review should be considered for the development of future paradigms.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 50 条
  • [1] Clinical trials in the elderly:: ethical and methodological considerations.
    Berdeu, D
    Hervé, C
    Fourcade, J
    REVUE DE MEDECINE INTERNE, 2000, 21 (07): : 614 - 622
  • [2] Review Article: Ethical Considerations in Conducting Clinical Trials
    Mousavinejad, Shahriar
    Bazmi, Shabnam
    Rezaei-Tavirani, Mostafa
    Shamsi-Gooshki, Ehsan
    Enjoo, Seyed Ali
    Kiani, Mehrzad
    INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE, 2021, 11 (04): : 34863
  • [3] Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality
    Staibano, Phillip
    Oulousian, Emily
    McKechnie, Tyler
    Thabane, Alex
    Luo, Samuel
    Gupta, Michael K.
    Zhang, Han
    Pasternak, Jesse D.
    Au, Michael
    Parpia, Sameer
    Young, J. E. M.
    Bhandari, Mohit
    PLOS ONE, 2024, 19 (05):
  • [4] Is it still ethical to conduct clinical trials against a placebo ? A review of the ethical and methodological controversy
    Bouvenot, G
    PRESSE MEDICALE, 2003, 32 (21): : 966 - 971
  • [5] Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges
    Garcia-Garcia, Irene
    Seco-Meseguer, Enrique
    Borobia, Alberto M.
    Carcas-Sansuan, Antonio J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (01) : 1 - 10
  • [6] Ethical Considerations in Decentralized Clinical Trials
    Bierer, Barbara E.
    White, Sarah A.
    JOURNAL OF BIOETHICAL INQUIRY, 2023, 20 (04) : 711 - 718
  • [7] Ethical considerations in clinical trials in Asia
    Tanida, N
    DRUG INFORMATION JOURNAL, 2002, 36 (01): : 41 - 49
  • [8] ETHICAL CONSIDERATIONS IN CLINICAL-TRIALS
    SHARPE, GJ
    CLEARY, MJ
    GALLETLY, DC
    ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (03) : 333 - 333
  • [9] Ethical considerations for nurses in clinical trials
    Oberle, K
    Allen, M
    NURSING ETHICS, 2006, 13 (02) : 180 - 186
  • [10] Ethical Considerations in Decentralized Clinical Trials
    Barbara E. Bierer
    Sarah A. White
    Journal of Bioethical Inquiry, 2023, 20 : 711 - 718